Enrico Picozza - 26 May 2021 Form 4 Insider Report for DermTech, Inc.

Role
Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Issuer symbol
N/A
Transactions as of
26 May 2021
Net transactions value
-$813,577
Form type
4
Filing time
28 May 2021, 20:18:27 UTC
Previous filing
25 May 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Award $0 +4,497 +32% $0.000000 18,497 26 May 2021 Direct F1
transaction DMTK Common Stock Award $0 +4,661 +25% $0.000000 23,158 26 May 2021 Direct F2
transaction DMTK Common Stock Sale $813,577 -20,297 -3.9% $40.08* 500,000 26 May 2021 By HLM Venture Partners IV, L.P. F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on May 26, 2022.
F2 The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest, and the shares underlying the restricted stock units shall be released to the reporting person, on January 1, 2023, subject to the reporting person's continued service.
F3 This transaction was executed in multiple trades at prices ranging from $40.00 to $40.32, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) of this Form 4.
F4 The reporting person has a pecuniary interest in HLM Venture Associates IV, LLC ("HLM GP"). HLM GP is the general partner of HLM Venture Partners IV, L.P., which owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.